Obesity… Weight loss interventions in rheumatology patients – diet, lifestyle, and bariatric surgery 10 Dec 202511 Dec 2025 Diet and lifestyle interventions Guidelines on lifestyle behaviours, including diet and exercise, to maintain healthy weight, promote physical health, and improve disease outcomes in individuals living with rheumatic and musculoskeletal…
Obesity… From Diabetes to Inflammation: The Expanding Therapeutic Landscape of GLP-1 receptor agonists and Multi-Hormone Receptor Modulators 10 Dec 2025 Glucagon-like peptide-1 (GLP-1) receptor agonists have attracted significant attention as a relatively new class of drugs. Initially developed for diabetes management, their therapeutic scope quickly expanded beyond glycemic control. They…
Obesity… Management of adverse skeletal effects following bariatric surgery procedures in people living with Obesity and Osteoporosis 10 Dec 202512 Dec 2025 Introduction Guidelines for preventing and treating osteoporosis resulting from bariatric surgery were provided in 2022 by the European Calcified Tissue Society (ECTS) (1) and the joint efforts of the Osteoporosis…
Obesity… More Than a Number: Weight Bias in Rheumatology Care 10 Dec 202511 Dec 2025 When I was first diagnosed with SLE/lupus, I gained 50 kilos — caused by a combination of corticosteroids, limited mobility, and constant fatigue. My body changed rapidly and so did…
EMEUNET… Stats Made Simple: Understanding Study Designs.Differences between observational, experimental, cross-sectional, and longitudinal studies 10 Dec 2025 Stefan Dinescu Rheumatologist, University of Medicine and Pharmacy Craiova, Romania EMEUNET Country Liaison for Romania Introduction When starting a research project, one of the most important steps is to establish…
Country Liaisons… Country Liaison Spotlight 10 Dec 2025 Highlights from the EMEUNET Session at the National Rheumatology Congress in Türkiye On 15th November 2025, young rheumatologists convened during the National Rheumatology Congress in Türkiye for a dedicated EMEUNET Introduction Session.…
ACR Highlights… ACR Convergence 2025 Highlights – Spondyloarthritis 24 Nov 202513 Dec 2025 The Assessments in Spondyloarthritis International Society (ASAS) and Spondyloarthritis Research and Treatment Network (SPARTAN) Revised Classification Criteria for Axial Spondyloarthritis: Development and Validation in the Classification of Axial SpA Inception…
ACR Highlights… ACR Convergence 2025 Highlights- Vasculitis 24 Nov 2025 MEthotrexate versus TOcilizumab for treatment of Giant cell Arteritis (METOGiA trial): a multicenter, randomized, controlled trial Abstract format and assignment number: Oral presentation 0891 Presenting author: M Samson (France) Date: Monday…
ACR Highlights… ACR Convergence 2025 Highlights- Paediatric rheumatology 24 Nov 2025 Efficacy of Tumor Necrosis Factor Inhibitors in Children Diagnosed With Non-Systemic Juvenile Idiopathic Arthritis <2 Years Old Using The Childhood Arthritis and Rheumatology Research Alliance Registry Abstract format and assignment…
ACR Highlights… ACR Convergence 2025 Highlights- Rheumatoid Arthritis 24 Nov 2025 A Phase 1 Study of Autologous CAR-Treg Cells in Refractory Rheumatoid Arthritis: Interim Report of Safety and Efficacy Abstract format and assignment number: Late-breaking abstract LB23 Presenting author: Kohler Minna…